Since organoids generated from hiPSC-ASPM-2 exhibited the more condensed cell mass and intact morphology than organoids derived from hiPSC-ASPM-1 or hiPSC-ASPM-3 (Figs. 4A and S4A), and all of organoids showed similar developing phenotypes, we utilized hiPSC-ASPM-2 as a representative for more detailed studies.
Biological treatment has been suggested to be able to improve the quality of these materials [ 40] as the polysaccharides including cellulose and hemicelluloses are converted into monomers such as glucose and xylose, and the latter are used for production of more fungal cell mass.
Fat accumulation occurs predominantly in visceral adipose tissue of the abdomen, which has more cells per mass unit.
The 'modified eversion theories' of Sheldon (1912), Northcutt and Braford (1980), and Yamamoto et al. (2007), just discussed, have in common that they all postulate a tangential shift of one or more pallial cell masses.
Vectors above or below the minor axis (meaning upper-left or lower-right half of ellipses) are associated with more or less cell mass in soft tissues, respectively, with extremes along the minor axis.
This study tested the hypothesis that immature ovine fetuses would expand their red cell mass more rapidly than near term fetuses after hemorrhage.
Four weeks of CMS, applied to the elastomeric scaffold, resulted in statistically greater DNA mass, more cell area coverage and a better distribution of cells deeper within the scaffold construct.
However, it was shown that early dividing blastomeres tend to divide asymmetrically more frequently, contributing more cells to the inner cell mass lineage [4]-[6].
Whether or not a blastomere divides asymmetrically does not seem to be determined randomly since early dividing blastomeres tend to do so more frequently, contributing more cells to the inner cell mass lineage [4]-[6].
Defining histopathological non-responding patients as having more than 50% remaining tumor cell mass in histopathological analysis, histopathological non-responders showed lower tissue levels of Follistatin than patients with more than 50% remaining tumor cells (p = 0.015).
